We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

New Genedata Expressionist for Mass Spectrometry

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, has announced that the new Genedata Expressionist for Mass Spectrometry. Compatible with data formats of all major MS vendors, Genedata Expressionist software significantly improves MS lab productivity. It provides an enterprise-level, integrated, and automated data analysis platform, which covers major biopharmaceutical applications including: characterization of post-translational modifications; glycosylation studies; mass analysis of intact proteins; and host cell protein analysis.
 
Data Processing Time Reduced from Weeks to Hours


Genedata Expressionist for Mass Spectrometry standardizes and automates the analysis of massive mass spectrometry datasets while offering state-of-the-art algorithms for high quality results. "We have implemented Genedata Expressionist for key parts of our workflow in biotherapeutics stability assessment and have successfully removed a major data analysis bottleneck," noted a senior scientist at Janssen R&D. "What previously took us a month of work, we do now within a day. And, Expressionist's excellent data visualization tools help to simplify our decision-making processes."
 
"We are excited and encouraged by the market adoption of Genedata Expressionist for Mass Spectrometry, which effectively addresses a data analysis bottleneck for our customers," said Dr. Othmar Pfannes, CEO of Genedata. "We are committed to advancing Genedata Expressionist as the vendor-agnostic platform of choice for MS data analysis and helping to make key processes in biopharmaceutical R&D as efficient as possible."